1-tert-Butyl 3-methyl 3-hydroxypyrrolidine-1,3-dicarboxylate, 95.0%, 5g

7-Chloro-3,4-dihydro-2H-benzo[b][1,4]oxazine, 97.0%, 250mg

2-N-Boc-Aminomethylmorpholine, 95.0%, 25g

TERT-BUTYL 4-(CYCLOPROPYLAMINO)-4-METHYLPIPERIDINE-1-CARBOXYLATE, 95.0%, 1g

(R)-PIPERIDINE-3-CARBOXAMIDE HCL, 95.0%, 500mg

5-Chloroisoindoline hydrochloride, 95.0%, 250mg

tert-butyl 4-(4-((8-ethyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)-2-fluorophenyl)piperazine-1-carboxylate, 98%, 50mg

Elution Tubes ROTI® MEGA, 3,5 kDa, 1 Piece(s), 10 ml

(4-(Methoxycarbonyl)-3-methylphenyl)boronic acid, 95.0%, 5g

3-(2-Methylpyridin-4-yl)propanoic acid, 97%, 5g

(2S)-2-azido-6-{[(tert-butoxy)carbonyl]amino}hexanoic acid, 99.0%, 1g

tert-Butyl 3-formyl-1H-pyrrolo[2,3-b]pyridine-1-carboxylate, 95.0%, 5g

bScope BS.1152-EPLPH for phase contrast. Biocular with HWF 10x/20 mm eyepieces and Quadruple revolver E-plan Phase 10/20/S40 S100x